VAERS reports by lot

Pfizer COVID-19 lot FP7141: VAERS reports

446 VAERS reports list lot FP7141 as a Pfizer COVID-19 vaccine, received between 2022-09-02 and 2024-04-26. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
446
Reports
2%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular5629%
General / Systemic (non-local)3719%
Neurological3518%
Respiratory2010%
Gastrointestinal168%
Thrombotic / Hematological84%
Dermatological (non-injection-site)74%
Psychiatric / Neuropsychiatric53%
Musculoskeletal42%
Allergic / Anaphylactic32%
Injection-site / Local reaction32%

Where reports came from

U.S. state of the reporter, where given (top 12).

Washington73
California43
Indiana25
Wisconsin19
Oregon18
Vermont17
Arizona13
Idaho13
North Carolina12
Illinois12
New York11
Delaware8

Reports by month received

2022-0992
2022-10202
2022-11107
2022-1223
2023-011
2023-022
2023-031
2023-046
2023-052
2023-061
2023-076
2023-111
2023-121
2024-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.